DIAGNOS Inc.
DGNOF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $104 | $170 | $439 | $267 |
| % Growth | -39% | -61.2% | 64.3% | – |
| Cost of Goods Sold | $1,047 | $1,008 | $857 | $615 |
| Gross Profit | -$944 | -$838 | -$418 | -$348 |
| % Margin | -909% | -492.4% | -95.3% | -130.1% |
| R&D Expenses | $0 | $0 | $603 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,881 | $1,769 | $2,242 | $1,936 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$13 | -$17 | $100 | $0 |
| Operating Expenses | $2,868 | $1,763 | $2,242 | $1,936 |
| Operating Income | -$3,811 | -$2,591 | -$2,554 | -$2,019 |
| % Margin | -3,671.7% | -1,522.5% | -582.1% | -756% |
| Other Income/Exp. Net | -$475 | -$530 | -$259 | $609 |
| Pre-Tax Income | -$4,286 | -$3,121 | -$2,608 | -$2,051 |
| Tax Expense | $0 | $0 | $154 | $296 |
| Net Income | -$4,286 | -$3,121 | -$2,608 | -$2,051 |
| % Margin | -4,129.6% | -1,833.9% | -594.4% | -768.1% |
| EPS | -0.049 | -0.043 | -0.038 | -0.03 |
| % Growth | -13.3% | -14.4% | -25.8% | – |
| EPS Diluted | -0.049 | -0.043 | -0.038 | -0.03 |
| Weighted Avg Shares Out | 88,279 | 72,822 | 69,617 | 68,735 |
| Weighted Avg Shares Out Dil | 88,279 | 72,822 | 69,617 | 68,735 |
| Supplemental Information | – | – | – | – |
| Interest Income | $50 | $7 | $8 | $5 |
| Interest Expense | $594 | $550 | $279 | $54 |
| Depreciation & Amortization | $128 | $124 | $101 | $106 |
| EBITDA | -$3,564 | -$2,446 | -$2,101 | -$2,449 |
| % Margin | -3,433.7% | -1,437.6% | -478.7% | -916.8% |